查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197374

實驗室冷凍機市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Laboratory Freezers Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，實驗室冷凍機市場預計將以 4.5% 的複合年增長率增長。

由於實驗室和診所的迅速關閉，以及全球冷凍機銷售和進口的下降，COVID-19 對實驗室冷凍機市場產生了重大影響。 然而，隨著 COVID-19 疫苗的推出和嚴格按照溫度設置儲存疫苗，對實驗室冰櫃和冰箱的需求增加了。 例如，根據 2022 年 10 月發布的“Moderna COVID-19”疫苗處理大綱，建議將疫苗保存在 -50度C 至 -15度C 的冰箱中直至到期。 此外，正如 2021 年 9 月發表的一篇論文所見，mRNA 平台使疫苗的快速開發成為可能，但由於需要超低溫儲存，其全球使用受到限制。 許多資源有限的國家缺乏冷鏈儲存來進行大規模疫苗接種。 因此，這個市場在大流行期間產生了重大影響。 此外，在後大流行時代，隨著限制的解除和 COVID-19 病例的減少，市場正在通過增加產品發布、實驗室冷凍設置的進步以及針對不同疾病的疫苗生產的增加而實現增長。。

血液和血液成分需求增加、器官移植手術數量增加以及實驗室冷凍機技術進步等因素正在推動預測期內的市場增長。 例如，根據 HRSA 2022 更新，美國將在 2021 年進行超過 40,000 例移植手術。 據同一消息來源稱，全國移植等待名單上有 105,842 人，包括男性、女性和兒童。 此外，根據 NHF 2022 更新，每年約有 400 名男性嬰兒出生時患有血友病 A，因此獻血和輸血漿的需求可能非常高，儲存需求也很高。實驗室級冰櫃預計將用於 因此，隨著血液相關問題的增加，對實驗室冷凍機的需求將會增加，從而推動預測期內的市場增長。

在各種因素的推動下，實驗室冷凍機行業在過去幾十年取得了廣泛的發展，包括製造商越來越重視開髮用於保存各種細胞的新產品。例如，2021 年 4 月，BioLife Solutions, Inc.，一家為細胞和基因治療提供一流生物生產產品和服務組合的開發商和供應商，宣布推出新的高容量可控速率冷凍機 (HCRF) 生產線和最初出貨給細胞治療公司。 此外，在實驗室冷凍機領域，產品發布、合作夥伴關係、併購預計將在預測期內推動市場增長。 例如，2022 年 1 月，Calibre Scientific 收購了總部位於英國牛津郡的實驗室耗材和設備分銷商 Medline Scientific。 Medline Scientific 進一步加強了 Calibre Scientific 在英國不斷增長的銷售業務。

由於對血液和血液成分的需求增加、實驗室冷凍產品的推出增加、實驗室冷凍技術的進步以及器官移植程序的增加，實驗室冷凍市場將在預測期內增長。預計將顯示 然而，實驗室冷凍機的高成本預計將在預測期內抑制全球市場的增長。

實驗室冷凍機市場趨勢

等離子冰箱領域預計在預測期內增長

血漿冷凍機使用-30 或-40 安全儲存血庫、實驗室、藥房和醫院血漿冷凍機中的新鮮冷凍血漿、紅細胞、濃縮血小板、疫苗和測試樣品。它提供並保持 度 的製冷溫度C。 由於單採術治療的增加和對新鮮冷凍血漿儲存 (FFP) 的需求增加，血漿冷凍機部分可能會出現顯著增長。 根據美國單採術協會 (ASFA)，血漿單採術是美國最常見的單採術。

此外，在預測期內，血漿冷凍領域的競爭對手、產品發布和合作預計將推動市場增長。 例如，2021 年 3 月，Helmer Scientific 推出了用於疫苗、藥物、血液療法和樣本儲存的 GX Solutions Laboratory 和 Plasma Freezers。 採用 OptiCool 技術的 GX Solutions 醫用級冷凍機專為關鍵醫療保健應用而設計，通過熱性能、降噪、減少能源使用和低全球變暖潛能值 (GWP) 來支持環境可持續性（比例因子）技術。

此外，在預測期內，政府對等離子存儲廠發展的舉措和資金預計將推動市場增長。 例如，2022 年 4 月，Terumo Blood and Cell Technologies 從美國政府獲得了 1060 萬美元的合同，繼續開發凍乾血漿。 該協議承認，醫療技術公司聯盟 MTEC 和 501(c)(3) 生物醫學技術聯盟已根據其他商業協議 (OTA) 與美國陸軍醫學研究與開發司令部合作，為戰場提供醫療保健。它由國防與健康管理局 (DHA) 贊助，由海軍醫學研究中心 (NMRC) 運營，旨在推動 因此，作為冷凍乾燥等離子優勢發展的一部分，預計對等離子乾燥機的需求將增加，從而推動預測期內的市場增長。

此外，獻血和輸血的增加預計將推動市場增長，因為血液中的血漿必須在獻血後 24 小時內冷凍以保存寶貴的凝血因子。例如，根據新加坡政府2022年5月的報告，42.6%的人捐了O+ve血，25.4%的人捐了B+ve血。 到 2022 年，新加坡每小時需要 14 個單位的血液。 這相當於每天 325 個學分，每年 118,750 個學分。

因此，由於獻血和輸血的增加、政府的舉措以及對血漿儲存廠發展的資助，預計血漿冷凍器部分在預測期內將出現增長。

預計在預測期內，北美的實驗室冷凍機市場將出現增長。

由於該地區領先公司的存在、器官移植的增加以及實驗室冷凍機的技術進步，預計北美實驗室冷凍機市場將顯著增長。 例如，根據CDC 2022更新，在美國，移植最多的器官是腎臟、肝臟、心臟、肺、胰腺和腸道。 此外，預計該地區獻血量的增加將推動預測期內的市場增長。 例如，根據美國紅十字會 2022 年的更新，在美國每兩秒鐘就有一個人需要血液和/或血小板。 因此，隨著獻血人數的增加，對實驗室冷凍櫃的需求也隨之增加，因為採集的血液被儲存在冷庫中，以保護輸血的血液成分。

此外，研究區域免疫接種的增加也有望在預測期內推動市場增長。 例如，根據 WHO 2022 更新，截至 2022 年 11 月，美國已收到 633,076,067 劑 COVID-19 疫苗。 隨著疫苗接種的增加，對實驗室冷凍櫃的需求也在增加，因為建議將疫苗儲存在標準溫度下的冷藏庫或冷凍櫃中，以保持疫苗的活力。 因此，研究區的市場預計會隨著冷凍櫃需求的增加而增長。 此外，研究區域與實驗室冷凍機相關的主要參與者的存在、收購、合併和聯盟預計將在預測期內推動市場增長。 例如，2021 年 10 月，創新測試和工藝解決方案供應商新澤西州 inTEST 公司將收購醫療冷鏈市場冷凍保存解決方案開發商 Z-Sciences Corp. 的大部分資產。一切都在

由於疫苗接種增加和獻血增加，在預測期內，北美地區的實驗室冷凍機市場可能會增長。

實驗室冷凍機市場競爭對手分析

這個市場的競爭很低。 實驗室冷凍機市場的主要參與者包括 Arctiko A/S、Antylia Scientific、LabRepCo Holding Corporation、Eppendorf AG、Evermed S.R.L.、Haier lnc.、Helmer Scientific、Panasonic Healthcare、Philipp Kirsch GmbH 和 Thermo Fisher Scientific, Inc。產品供應世界各地。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 對血液和血液成分的需求增加
    • 增加器官移植手術的數量
    • 實驗室冷凍機的技術進步
  • 市場製約因素
    • 實驗室冰箱成本高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按類型
    • 等離子冰箱
    • □冰箱
    • 可燃冷凍機
    • 其他
  • 最終用戶
    • 血庫
    • 醫學實驗室
    • 製藥公司、生物技術公司
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Arctiko A/S
    • Antylia Scientific
    • LabRepCo Holding Corporation
    • Eppendorf AG
    • Evermed S.R.L.
    • Haier lnc.
    • Helmer Scientific
    • Panasonic Healthcare Co., Ltd.
    • Philipp Kirsch GmbH
    • Thermo Fisher Scientific, Inc.

第7章 市場機會與今後動向

簡介目錄
Product Code: 67570

The laboratory freezers market is poised to grow at a CAGR of 4.5% over the forecast period.

COVID-19 had a significant impact on the laboratory freezers market owing to the factors such as the rapid shut of laboratories and clinics led to decreased sales as well as the import of freezers worldwide. Even though, as the vaccine for COVID-19 had been introduced, the demand for laboratory freezers and refrigerators increased as vaccine storage strictly followed the temperature settings. For instance, as per the Moderna COVID-19 vaccine handling summary published in October 2022, vaccines are advised to be stored in freezers between -50°C and -15°C (-58°F and 5°F) until the expiration date. Furthermore, as per the article published in September 2021, the mRNA platform allowed for the rapid development of vaccines, but their global use was limited by the need for ultracold storage. Most resource-constrained countries lack cold chain storage to carry out mass vaccinations. Hence, the studied market witnessed a significant impact throughout the pandemic phase. Furthermore, in the post-pandemic era, as the restrictions were lifted and COVID-19 cases were reduced, the market is witnessing growth through the rise in product launches, advancements in laboratory freezer settings, and an increase in vaccine production for different diseases.

Factors such as increasing demand for blood and blood components, the growing number of organ transplant procedures, and technological advancements in laboratory freezers drive market growth over the forecast period. For instance, as per the HRSA 2022 update, in the United States, more than 40,000 transplants were performed in 2021. As per the same source, there are 105,842 people including men, women, and children on the national transplant waiting list. Furthermore, as per the 2022 update from NHF, every year, 400 or so male babies are born with hemophilia A. Hence, there is likely to be a huge need for blood donation and plasma transfusions, which is anticipated to utilize cold storage or laboratory-grade freezers for preservation. Hence, as the number of blood-related issues increases, the laboratory freezer demand rises thereby boosting the market growth over the forecast period.

The laboratory freezers industry has observed extensive developments in the last few decades supported by various factors such as a rise in the focus of manufacturers on developing novel products for preserving different cells. For instance, in April 2021, BioLife Solutions, Inc., a developer, and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, launched a new line of high-capacity controlled rate freezers (HCRF), with an initial shipment to a cell therapy company. Furthermore, product launches, collaborations, mergers, and acquisitions in the field of laboratory freezers are anticipated to boost market growth over the forecast period. For instance, in January 2022, Calibre Scientific acquired Medline Scientific, a distributor of laboratory consumables and equipment with headquarters in Oxfordshire, United Kingdom. Medline Scientific further enhances Calibre Scientific's growing distribution presence in the United Kingdom.

Therefore, due to the increasing demand for blood and blood components, the rise in laboratory freezer product launches, technological advancements in a laboratory freezers, and a growing number of organ transplant procedures, the laboratory freezers market is anticipated to witness growth over the forecast period. However, the high cost of laboratory freezers is expected to restrain the growth of the global market over the forecast period.

Laboratory Freezers Market Trends

Plasma Freezers Segment is Expected to Witness a Growth Over the Forecast Period

Plasma freezers provide and maintain the freezing temperature at -30 or -40 °C for safe storage of fresh frozen plasma, red cells, and platelet concentrates whole blood, vaccines, and test samples in blood banks, research institutes, pharmacies, and hospital plasma freezers. The plasma freezers segment is likely to witness significant growth owing to an increase in the number of apheresis treatments and an increase in demand for fresh frozen plasma storage (FFP). Plasma exchange is the most prevalent apheresis technique in the United States, according to the American Society for Apheresis (ASFA).

Furthermore, the presence of competitors, product launches, and collaborations in the field of plasma freezers are likely to boost the market growth over the forecast period. For instance, in March 2021, Helmer Scientific launched GX Solutions Laboratory and Plasma Freezers for vaccines, medications, blood therapies, and sample storage. Powered by OptiCool technology GX Solutions medical-grade freezers are designed for important healthcare applications through temperature performance, noise reduction, and reduced energy use, while also using low Global Warming Potential (GWP) technology to assist environmental sustainability.

Moreover, government initiatives and funding for the development of plasma storage plants are anticipated to boost market growth over the forecast period. For instance, in April 2022, Terumo Blood and Cell Technologies received USD 10.6M contract From U.S. Government to continue freeze-dried plasma development. The contract is with MTEC, the Medical Technology Enterprise Consortium, a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command and is sponsored by the Defense Health Agency (DHA) and managed by the Naval Medical Research Center (NMRC) to drive healthcare advances for the battlefield. Hence, as a part of the development owing to the advantages of freeze-dried plasma, the demand for plasma dryers is likely to increase, thereby driving market growth over the forecast period.

Additionally, the increase in blood donation and transfusions are anticipated to boost the market growth since the plasma from the blood needs to be frozen within 24 hours of being donated to preserve the valuable clotting factors. For instance, as per the May 2022 report from the Government of Singapore, 42.6% of people donated O+ve blood and 25.4% donated B+ve blood. In 2022, 14 units of blood are required every hour in Singapore. That is 325 units every day or 118,750 units in the year.

Hence, due to the rise in blood donations and transfusions, and the increase in government initiatives and funding for the development of plasma storage plants, the plasma freezers segment is anticipated to witness growth over the forecast period.

North America is Expected to Witness a Growth in the Laboratory Freezers Market Over the Forecast Period

The laboratory freezers market in the North American region is anticipated to grow significantly as a result of the presence of prominent players in the region, the growing number of organ transplant procedures, and technological advancements in laboratory freezers. For instance, according to the CDC 2022 update, in the United States, the most transplanted organs are the kidney, liver, heart, lungs, pancreas, and intestines. Furthermore, a rise in blood donation in the region is anticipated to boost the market growth over the forecast period. For instance, as per the 2022 update from American Red Cross, every 2 seconds someone in the U.S. needs blood and or platelets. Approximately 29,000 units of red blood cells are needed every day in the U. S. Hence, as the number of blood donations increases, the demand for laboratory freezers also rises as the collected blood is stored in cold storage to protect the blood components for transfusion.

Furthermore, the rise in vaccinations and immunization programs in the studied region is likely to boost market growth over the forecast period. For instance, as per the WHO 2022 update, 633,076,067 COVID-19 vaccine doses had been administered in the United States as of November 2022. As a result of the increase in vaccinations, there is a strong need for laboratory freezers, as vaccines are advised to keep in cold storage or a freezer under a standard temperature to keep them viable. As a result, as the demand for freezers increases, the market is likely to grow in the studied region. Moreover, the presence of key players, acquisitions, mergers, and collaborations related to the laboratory freezers in the studied region is anticipated to boost market growth over the forecast period. For instance, in October 2021, New Jersey-based inTEST Corporation, a supplier of innovative test and process solutions acquired substantially all of the assets of Z-Sciences Corp., a developer of ultra-cold storage solutions for the medical cold chain market.

Hence, due to the rise in vaccinations and immunization programs and the rise in blood donation, the laboratory freezers market is likely to witness growth in the North America region over the forecast period.

Laboratory Freezers Market Competitor Analysis

The market studied is moderately competitive. Some of the major players in the laboratory freezers market include Arctiko A/S, Antylia Scientific, LabRepCo Holding Corporation, Eppendorf AG, Evermed S.R.L., Haier lnc., Helmer Scientific, Panasonic Healthcare Co., Ltd., Philipp Kirsch GmbH, and Thermo Fisher Scientific, Inc. which provides these products across the globe.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Blood and Blood Components
    • 4.2.2 Growing Number of Organ Transplant Procedures
    • 4.2.3 Technological Advancements in Laboratory Freezers
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Laboratory Freezers
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Plasma Freezers
    • 5.1.2 Enzyme Freezers
    • 5.1.3 Flammable Material Freezers
    • 5.1.4 Others
  • 5.2 By End User
    • 5.2.1 Blood Banks
    • 5.2.2 Medical Laboratories
    • 5.2.3 Pharmaceutical & Biotechnology Companies
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arctiko A/S
    • 6.1.2 Antylia Scientific
    • 6.1.3 LabRepCo Holding Corporation
    • 6.1.4 Eppendorf AG
    • 6.1.5 Evermed S.R.L.
    • 6.1.6 Haier lnc.
    • 6.1.7 Helmer Scientific
    • 6.1.8 Panasonic Healthcare Co., Ltd.
    • 6.1.9 Philipp Kirsch GmbH
    • 6.1.10 Thermo Fisher Scientific, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS